Skip to main content


Figure 2 | BMC Immunology

Figure 2

From: Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells

Figure 2

Peribronchila inflammation score and immunoglobulin levels in serum. The peribronchial inflammation score and OVA-sIgE levels in OVA group and OVA323-339 group were significantly increased, but they were significantly decreased accompanied by increased OVA-sIgG1 after OVA323-339MAP treatment (* compared with the control group, P < 0.05; # compared with the OVA323-339 group, P < 0.05). Data represent one of three independent experiments.

Back to article page